14. AbbVie Inc (NYSE:ABBV)
AbbVie Inc (NYSE:ABBV) is another biopharmaceutical company, which had sales of $25.56 billion last year (up by 13.3%), mainly driven by its blockbuster drug Humira, which had sales of $16.08 billion. The company’s stock is 16% in the green year-to-date and sports a dividend yield of 3.53%. AbbVie Inc (NYSE:ABBV) was held by 64 funds from our database, which collectively owned roughly $3.40 billion worth of its stock at the end of March. That was up from 54 funds long AbbVie Inc (NYSE:ABBV) a quarter earlier.